Chemoinformaics analysis of 2-(1-HYDROXYETHYL)-2-ACETYL-NAPHTHO[2,3-B]FURAN-4,9-DIONE
Molecular Weight | 286.283 | nRot | 2 |
Heavy Atom Molecular Weight | 272.171 | nRig | 18 |
Exact Molecular Weight | 286.084 | nRing | 3 |
Solubility: LogS | -3.242 | nHRing | 1 |
Solubility: LogP | 0.882 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 5 | APOL | 40.0651 |
nHD | 1 | BPOL | 18.3849 |
QED | 0.88 |
Synth | 4.076 |
Natural Product Likeliness | 0.919 |
NR-PPAR-gamma | 0.103 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.009 |
Pgp-sub | 0.004 |
HIA | 0.006 |
CACO-2 | -4.678 |
MDCK | 0.000029 |
BBB | 0.803 |
PPB | 0.759443 |
VDSS | 0.941 |
FU | 0.202384 |
CYP1A2-inh | 0.369 |
CYP1A2-sub | 0.636 |
CYP2c19-inh | 0.111 |
CYP2c19-sub | 0.714 |
CYP2c9-inh | 0.072 |
CYP2c9-sub | 0.09 |
CYP2d6-inh | 0.015 |
CYP2d6-sub | 0.223 |
CYP3a4-inh | 0.025 |
CYP3a4-sub | 0.508 |
CL | 2.885 |
T12 | 0.377 |
hERG | 0.014 |
Ames | 0.971 |
ROA | 0.854 |
SkinSen | 0.59 |
Carcinogencity | 0.735 |
EI | 0.022 |
Respiratory | 0.962 |
NR-Aromatase | 0.663 |
Antiviral | Yes |
Prediction | 0.797082 |